Abstract:Abstract Background Gliomas are the most common and aggressive primary brain tumors for which unfortunately no effective treatment modalities exist despite advances in molecular biology as the knowledge base to unravel the extremely complex molecular mechanisms of tumorigenesis is limited. In this study an attempt has been made to understand the molecular pathological basis of tumorigenesis which led to an identification of an oncogene, CDC2, and an epigenetic strategy has been evaluated to control the tumorigensis by downregulating this oncogene. Methods Tissue microarrays were utilized to investigate the expression of genes in a large number of tumor samples and to identify overexpressed genes which could be potentially causing tumorigenesis. Retroviral vectors expressing short hairpin RNAs (shRNAs) targeted against CDC2 were designed and transducted into human glioma cell line ex vivo in order to downregulate the expression of CDC2. Real-Time PCR was used to determine the level of CDC2 mRNA. Western Blotting was used to determine the level of expression of CDC2 protein as measure to quantify down regulation of CDC2 expression along with use of flow cytometry to investigate effect of shRNAs on cell cycles and detection of apoptosis. Following ex vivo study, viral particles containing small interfering RNA for CDC2 were subsequently injected into xenogeneic graft tumor of nude mice and the weight of human glioma xenografts, survival and resulting phenotypic changes of target gene were investigated. Results Human glioma tissue microarrays indicated the positive expression rates of CDC2/CyclinB1 with a positive correlation with pathologic grades (r = 0.982, r = 0.959, respectively). Retroviral vectors expressing short hairpin RNAs (shRNAs) against CDC2 caused efficient deletion of CDC2, cellular G2/M arrest concluding in apoptosis and inhibition of proliferation in human glioma cells U251 and SHG-44 cell lines ex vivo. And the viral particles containing small interfering RNA for CDC2 were subsequently injected into subcutaneous and intracranial xenogeneic graft tuomrs of nude mice. For subcutaneous tumors, injection of CDC2-shRNA retroviruses significantly decreased tumor weight and volume compared with control. Immunohistochemistry indicated that CDC2 are negative and TUNEL are positive in tumors treated with recombinant retrovirus. For mice implanted with intracranial gliomas, treatment of CDC2-shRNA retroviruses increased survival times compared with control. Conclusion CDC2 gene plays an important role in the proliferation of human gliomas. Downregulation of CDC2 could potentialy inhibit human gliomas cells growth ex vivo and in vivo. From these results, it was suggested that CDC2 might be a potential target on gene therapy of human gliomas.

Knockdown of Cyclin D1 Inhibits Proliferation, Induces Apoptosis, and Attenuates the Invasive Capacity of Human Glioblastoma Cells

Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity

MicroRNA-181 Inhibits Glioma Cell Proliferation by Targeting Cyclin B1.

CDK5 Knockdown inhibits proliferation and induces apoptosis and Cell Cycle Arrest in Human Glioblastoma

Study on the Cell Cycle Regulation of Cyclin D1 in U87 Glioma Cells

Effect of silencing cyclin-dependent kinase-like 1 gene by RNA interference on proliferation and apoptosis in human U251 glioma cells

Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomas

Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells <it>in vitro </it>and <it>in vivo</it>

Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo

Knocking Down Cyclin D1b Inhibits Breast Cancer Cell Growth and Suppresses Tumor Development in a Breast Cancer Model

Gli1 Inhibition Induces Cell-Cycle Arrest and Enhanced Apoptosis in Brain Glioma Cell Lines

Inhibition of EGR1 Inhibits Glioma Proliferation by Targeting CCND1 Promoter

[CDK1 Expression and Effects of CDK1 Silencing on the Malignant Phenotype of Glioma Cells].

Knockdown of ubiquitin-conjugating enzyme E2C/UbcH10 expression by RNA interference inhibits glioma cell proliferation and enhances cell apoptosis in vitro

Knockdown of Akt2 Expression by Rna Interference Inhibits Proliferation, Enhances Apoptosis, and Increases Chemosensitivity to the Anticancer Drug Vm-26 in U87 Glioma Cells

Downregulation of Nuclear Protein-1 Induces Cell Cycle Arrest in G0/G1 Phase in Glioma Cells in Vivo and in Vitro Via P27

Lentiviral Vector Mediated Delivery of RHBDD1 shRNA down Regulated the Proliferation of Human Glioblastoma Cells

ID1 regulates U87 human cell proliferation and invasion.

Knockdown of HMGB1 Improves Apoptosis and Suppresses Proliferation and Invasion of Glioma Cells.

Cyclin G2 reverses immunosuppressive tumor microenvironment and potentiates PD-1 blockade in glioma

Inhibition of the CyclinD1 Promoter in Response to Sonic Hedgehog Signaling Pathway Transduction is Mediated by Gli1.